相关实验视频

Updated: Jul 18, 2025

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

在固体瘤瘤学中抗体-药物结合物:具有有针对性的有效载荷的有效性付款日

Aleksei Kondrashov¹, Surendra Sapkota¹, Aditya Sharma²

¹Department of Internal Medicine, Saint Agnes Hospital, Baltimore, MD 21229, USA.

|August 26, 2023

概括

抗体-药物合物 (ADC) 通过将强效药物直接输送到瘤细胞,提供向癌症治疗. 虽然有效,但瘤进化和成本对这些先进的瘤治疗方法构成挑战.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
生物技术是生物技术.

背景情况:

抗体与药物联合体 (ADCs) 与传统化疗相比,是一个显著的进步.
ADCs利用抗体向癌细胞上的特定抗原,精确地传递细胞毒性有效载荷.
与传统化疗相比,这种有针对性的方法最大限度地降低了全身毒性.

研究的目的:

审查抗体-药物联合体 (ADC) 的基本结构和功能.
讨论ADC中使用的各种各样的有效载荷和链接技术.
探索目前的临床研究和ADC在固体瘤治疗中的未来潜力.

主要方法:

审查关于ADC开发和临床应用的现有文献.
对ADC组件的分析:抗体,链接器和细胞毒性有效载荷.
在固体瘤中检查FDA批准的ADC及其向抗原.

主要成果:

ADCs已在各种固体瘤中表现出有效性,包括乳腺癌,肺癌和卵巢癌.
目前有6种ADC被FDA批准用于固体瘤治疗,它们向HER2,nectin-4,Trop2,组织因子和叶酸受体α等抗原.
有效载荷通常包括微管抑制剂,拓酶抑制剂和化剂,具有影响疗效的链接特性.

结论:

ADCs为固体恶性瘤提供了有希望的向治疗,扩大了超出血液癌症的治疗选择.
诸如瘤抗原演变和高成本等挑战需要对新的ADC策略进行持续研究.
对新的ADC及其治疗潜力的持续研究对于推进癌症治疗至关重要.

关键词:

无神论的目标是不可知性的目标.抗体药物联合体抗体药物联合体新奇的治疗方法.精确瘤学精确瘤学固体瘤是一种固体瘤.有针对性的治疗.

更多相关视频

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...